Discovery complete, insights ready for review

The first findings are in. Review them to let Mapping & Synthesis build on them.

Acute Lymphoblastic Leukemia United States Build Claims Line of Therapy RUN-B09E17F3

Market & Clinical Context

In progress Review the findings

Clinical landscape and treatment evidence, researched from approved sources.

  1. Discovery
  2. Review gate
  3. Mapping & Synthesis
  4. Final approval
  5. Approved document
Discovery complete 33%
2 of 6 research areas done Details

100% done · open to see each research area

Review gate. Discovery is finished. The next part waits for your decisions.

0% done · open to see each research area

Discovery complete, 9 insights generated
9insights
9ready as written
180evidence items
15sources used
0source conflicts
Evidence came from
National Cancer Institute (NCI)29FDA Drug Labeling (openFDA)11PubMed6Orphanet / Orphadata10ESMO20FDA Drugs@FDA (openFDA)9ClinicalTrials.gov14NCI SEER5WHO Global Health Observatory1ASH / Blood (American Society of Hematology)29ASCO15CDC / NCHS3WHO3FDA2Open Web (Supplementary)23